Frequency of TEL/AML1 and BCR/ABL fusion genes in children with acute lymphoblastic leukemia;Frecuencia de los genes de fusión TEL/AML1 y BCR/ABL en pacientes pediátricos con leucemia linfoblástica aguda

Revista Medica de Chile

Volumn 134, Issue 11, 2006, Pages 1367-1376

  Artigas Allaire, Carmen Gloria ^a   Cabrera C, María Elena ^b   Melo A, Angélica ^c   Páez F, Eduardo ^c   Arriagada M, Mónica ^c   Astete A, Carmen ^d   Roa E, Iván ^a,c   Roa S, Juan Carlos ^c  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD DE LA FRONTERA   (Chile)

^d HOSPITAL LUIS CALVO MACKENNA   (Chile)

Author keywords

BCR ABL; Fusion proteins; Leukemia, lymphocytic, acute; TEL AML1 fusion protein

Indexed keywords

BCR ABL PROTEIN; ONCOPROTEIN; TEL AML1 FUSION PROTEIN; TEL-AML1 FUSION PROTEIN; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; FEMALE; GENE TRANSLOCATION; GENETICS; HUMAN; INFANT; LYMPHATIC LEUKEMIA; MALE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; INFANT; MALE; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 33846282327     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. SAWYERS C. Molecular genetics of acute leukaemia. Lancet 1997; 349: 196-200.
2. PUI CH, EVANS W. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-15.
3. PUI CH, RELLING M, DOWNING J. Mechanisms of Disease: Acute Lymphoblastic Leukemia. N Eng J Med 2004; 350: 1535-48.
4. LOOK AT. Genes altered by chromosomal translocations in leukemias and lymphomas. En: Vogelstein B, Kenneth K. The genetics basic of human cancer. New York: McGraw-Hill, 1998; 109-41.
5. BIONDI A, CIMINO, G, PIETERS R, PUI CH. Biological and therapeutic aspects of infant leukaemia. Blood 2000; 96: 24-33.
6. VAN DONGEN JJ, MACINTYRE EA, GABERT JA, DELABESSE E, ROSSI V, SAGLIO G ET AL. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-28.
7. GOLUB TR, BARKER GF, BOHLANDER SK, HIEBERT SW, WARD DC, BRAY-WARD P ET AL. Fusion of TEL gene on 12p13to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-21.
8. WIEMELS J, FORD A, VAN WERING E, POSTMA A, GREAVES M. Protracted and variable latency of acute lymphoblastic leukemia after TEL/AML1 gene fusion in utero. Blood 1999; 94: 1057-62.
9. FORD AM, FASCHING K, PANZER-GRUMAYER R, KOENING M, HAAS O, GREAVES MF. Origins of «late» relapse in childhood acute lymphoblastic leukaemia with TEL-AML1 fusion genes. Blood 2001; 98: 558-64.
10. GREAVES M, WIEMELS J. Origins of chromosome translocations in childhood leukaemia. Nature Rev Cancer 2003; 3: 1-11.
11. MAGALHAES IQ, POMBO-DE-OLIVEIRA MS, BENNETT CA, CORDOVA JC, DOBBIN J, FORD AM ET AL. TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 2000; 111: 204-7.
12. UCKUN FM, PALLISGAARD N, HOKLAND P, NAVARRA C, NARLA R, GAYNON PS ET AL. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukaemia. Leuk Lymphoma 2001; 42: 41-56.
13. BORKHARDT A, CAZZANIGA G, VIEHMANN S, VALSECCHI MG, LUDWIG W-D, BURCI L ET AL. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Blood 1997; 90: 571-7.
14. ROMANA SP, POIREL M, LECONIAT M, FLEXOR MA, MAUCHAUFFE M, JONVEAUX P ET AL. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263-9.
15. TRKA J, ZUNA J, HRUSAK O, KALINOVA M, MUZIKOVA K, LAUSCHMAN H ET AL. Impact of TEL-AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Leukemia 1998; 12: 996-1007.
16. OZBEK U, SIRMA S, AGAOGLU L, YUKSEL L, ANAK S, YILDIZ I ET AL. Prognostic significance of the TELAML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey. J Pediatr Hematol Oncol 2003; 25: 204-8.
17. AMOR DJ, ALGAR EM, SLATER HR, SMITH PJ. High frequency of t(12;21) in childhood acute leukemia detected by RT-PCR. Pathology 1998; 30: 381-5.
18. ENDO C, ODA M, NISHIUCHI R, SEINO Y. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission. Pediatrics Int 2003; 45: 275-80.
19. HUBEEK I, RAMAKERS-VAN WOERDEN NL, PIETERS R, SLATERR, BEVERLOO HB, VAN WERING E ET AL. TELAML1 fusion is not a prognostic factor in dutch childhood acute lymphoblastic leukemia. Br J Haematol 2001; 113: 254-5.
20. LOH M, SILVERMAN L, YOUNG M, NEUBERG D, GOLUB T, SALLAN S ET AL. incidence of TEL/AML1 fusion in children with relapsed childhood acute lymphoblastic leukemia. Blood 1998; 92: 4792-7.
21. RUBNITZ JE, SHUSTER JJ, LAND VJ, LINK MP, PULLEN J, CAMITTA BM ET AL. Case control study suggests a favorable impact of TEL rearrangement in patients with B lineage acute lymphoblastic leukemia treated with antimetabolite based therapy: A Pediatric Oncology Group study. Blood 1997; 89: 1143-6.
22. ATTARBASCHI A, MANN G, KÖNIG M, DWORZAK MN, TREBO MM, MÜHLEGGER N ET AL. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukaemia: an interphase FISH analysis. Leukemia 2004; 18: 1611-16.
23. HANN I, VORA A, HARRISON G, HARRISON C, EDEN O, HILL F ET AL. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001; 113: 103-14.
24. SEEGER K, STACKELBERG A, TAUBE T, BUCHWALD D, KORNER G, SUTTORP M ET AL. Relapse of TEL-AML1-positive acute lymphoblastic leukemia in childhood: A matched-pair analysis. J Clin Oncol 2001; 19: 3188-93.
25. ROBINSON HM, BROADFIELD ZJ, CHEUNG KL, HAREWOOD L, HARRIS RL, JALALI GR ET AL. Amplification of AML1 in acute lymphoblastic leukaemia is associated with a poor outcome. Leukemia 2003; 17: 2249-50.
26. NOWELL PC, HUNGERFORD DA. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497-500.
27. BEYERMANN B, ADAMS HP, HENZE G. Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia; a matched-pair analysis. J Clin Oncol 1997; 15: 2231-7.
28. UCKUN EM, NACHMANN JB, SATHER HN, SENSEL MG, KRAFT P, STENHERZ PG ET AL. Poor treatment outcome of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leuk Lymph 1999; 33: 101-6.
29. BARRIGA F, RISUEÑO C, LEGUES ME, CAMPBELL M, TORDESILLA J ET AL. Transcriptos de fusión TELAML1 en niños con Leucemia linfoblástica Aguda (LLA) de estirpe B. Rev Chil Cancerología y Hematología 1997; 7: 226 (Abstract).
30. ARTIGAS CG, MELO A, ROA JC, PÁEZ E, VITTINI C, ARRIAGADA M ET AL. Detección de secuencias del gen BCR-ABL mediante RT-PCR en pacientes con leucemia en la IX Región. Chile. Rev Méd Chile 2002; 130: 623-30.
31. CABRERA ME, CAMPBELL M, QUINTANA J, UNDURRAGA S, FORD A, GRAVES M. Significado clínico y frecuencia de la alteración genético/molecular 11q23/MLL en lactantes con leucemia aguda en Chile. Rev Méd Chile 2001; 129: 634-42.
32. ARTIGAS CG, MELO A, ROA JC, ROA I, QUIJADA I, VITTINI C ET AL. Transcriptos de fusión del gen BCR/ABL en pacientes con leucemia mieloide crónica. Int J Morphol 2003; 21: 205-9.
33. CABRERA ME, LABRA S, UGARTE S, MATUTES E, GREAVES MF. Inmunofenotipo, características clínicas y laboratorio de la leucemia linfoblástica aguda en Chile. Rev Méd Chile 1996; 124: 293-9.
34. WILLIAMS DL, HARRIS A, WILLIAMS KJ, BROSIUS MJ, LEMONDS W. A direct bone marrow chromosome technique for acute lymphoblastic leukaemia. Cancer Genet Cytogenet 1984; 13: 239-57.
35. MITELMAN F. Standing Committee on Human Cytogenetic. ISCN 1995. An International System for Human Cytogenetic Nomenclature. Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Memphis, Tennessee: Basel S Karger Pub, 1995.
36. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
37. ARTIGAS CG, MELO A. Gen DRB-1: Su utilidad como control interno en la técnica de reacción en cadena de la polimerasa con transcriptasa reversa (RT-PCR). Rev Chil Cs Méd Biol 2000; 10: 47-50.
38. CROSS N. Detection of BCR-ABL in Hematological Malignancies by RT-PCR. En: Cotter F. ed. Molecular diagnosis of cancer. Totowa, New Jersey: Humana Press, 1996; 25-36.
39. CENSO 2002. Comisión Nacional del XVII Censo de Población y VI de Vivienda. Santiago de Chile, Marzo, 2003. Consultado en: http://www.ine.cl/cd2002/etnia.pdf
40. BOROWITZ M, DIGIUSEPPE J. Acute Lymphoblastic Leukemia. En: Knowles D. ed. Neoplastic Hematopathology. Philadelphia: Lippincott Williams & Wilkins, 2001; 1643-65.
41. RAYNAUD S, CAVE H, BAENS M, BASTARD C, CACHEUX V, GROSGEORGE J ET AL. The 12;21 Translocation Involving TEL and Deletion of the Other TEL Allele: Two Frequently Associated Alterations Found in Childhood Acute Lymphoblastic Leukemia. Blood 1996; 87: 2891-9.
42. MA SK, WAN TS, CHEUK AT, FUNG LF, CHAN GC, CHANG SY ET AL. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study. Leukemia 2001; 15: 1442-7.
43. DOUET-GUILBERT N, MOREL F, LE BRIS MJ, HERRY A, LE CALVEZ G, MARION V ET AL. A fluorescence in situ hybridization study of TEL/AML1 fusion gene in B-cell acute lymphoblastic leukemia (1984-2001). Cancer Genet Cytogenet 2003; 144: 143-7.
44. DE HAAS V, OOSTEN L, DEE R, VERHAGEN O, KROES W, VAN DER BERG H ET AL. Minimal residual disease studies are beneficial in the follow - up of TEL / AML1 patients with B-precursor acute lymphoblastic leukaemia. Br J Haematol 2000; 111: 1080-6.
45. TSANG KS, LI CK, CHIK KW, SHING MM, TSOI WC, NG MH ET AL. TEL/AML1 rearrangement and the prognosis significance in childhood acute lymphoblastic leukemia in Hong Kong. Am J Hematol 2001; 68: 91-8.
46. CAMPBELL M, SALGADO C, QUINTANA J, BECKER A, VARGAS L, CABRERA ME ET AL. Mejoría en el pronóstico de la leucemia linfoblástica aguda en niños de un país en desarrollo: Resultados del protocolo nacional chileno PINDA 87. Rev Chil Pediatr 1999; 70: 405-14.